123 related articles for article (PubMed ID: 6987989)
1. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis.
Gay RE; Buckingham RB; Prince RK; Gay S; Rodnan GP; Miller EJ
Arthritis Rheum; 1980 Feb; 23(2):190-6. PubMed ID: 6987989
[TBL] [Abstract][Full Text] [Related]
2. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
Buckingham RB; Prince RK; Rodnan GP
J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine/monokine inhibition of fibroblast proliferation and collagen production: role in progressive systemic sclerosis (PSS).
Duncan MR; Perlish JS; Fleischmajer R
J Invest Dermatol; 1984 Nov; 83(5):377-84. PubMed ID: 6333468
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
Feghali CA; Boulware DW; Levy LS
J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
[TBL] [Abstract][Full Text] [Related]
5. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.
Jimenez SA; Feldman G; Bashey RI; Bienkowski R; Rosenbloom J
Biochem J; 1986 Aug; 237(3):837-43. PubMed ID: 3800922
[TBL] [Abstract][Full Text] [Related]
6. Collagen in the cellular and fibrotic stages of scleroderma.
Fleischmajer R; Gay S; Meigel WN; Perlish JS
Arthritis Rheum; 1978 May; 21(4):418-28. PubMed ID: 350229
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma).
Wallis DD; Tan FK; Kielty CM; Kimball MD; Arnett FC; Milewicz DM
Arthritis Rheum; 2001 Aug; 44(8):1855-64. PubMed ID: 11508439
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
[TBL] [Abstract][Full Text] [Related]
9. Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis.
Cooper SM; Keyser AJ; Beaulieu AD; Ruoslahti E; Nimni ME; Quismorio FP
Arthritis Rheum; 1979 Sep; 22(9):983-7. PubMed ID: 383087
[TBL] [Abstract][Full Text] [Related]
10. Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures.
Krieg T; Perlish JS; Fleischmajer R; Braun-Falco O
Arch Dermatol Res; 1985; 277(5):373-6. PubMed ID: 4026379
[TBL] [Abstract][Full Text] [Related]
11. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotides and calcium transport in cultured dermal fibroblasts from progressive systemic sclerosis and rheumatoid arthritis patients.
Grozdova MD; Khokhlova JV; Panasyuk AF; Guseva NG; Trofimova TM
Arthritis Rheum; 1984 Oct; 27(10):1144-9. PubMed ID: 6091700
[TBL] [Abstract][Full Text] [Related]
13. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
Gruschwitz M; Sepp N; Kofler H; Wick G
Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis.
Janin A; Konttinen YT; Grönblad M; Karhunen P; Gosset D; Malmström M
Clin Exp Rheumatol; 1990; 8(3):237-42. PubMed ID: 2165882
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels.
Rosenbloom J; Feldman G; Freundlich B; Jimenez SA
Arthritis Rheum; 1986 Jul; 29(7):851-6. PubMed ID: 3091039
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.
Feghali CA; Bost KL; Boulware DW; Levy LS
J Rheumatol; 1992 Aug; 19(8):1207-11. PubMed ID: 1404155
[TBL] [Abstract][Full Text] [Related]
17. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).
Buckingham RB; Prince RK; Rodnan GP; Taylor F
J Lab Clin Med; 1978 Jul; 92(1):5-21. PubMed ID: 351108
[No Abstract] [Full Text] [Related]
18. [Characteristics of collagen protein biosynthesis in fibroblast cultures from the skin of patients with systemic scleroderma].
Vladimirtsev VA; Guseva NG; Khokhlova IuV; Oskilko TG
Vopr Revm; 1981; (2):44-50. PubMed ID: 6275609
[No Abstract] [Full Text] [Related]
19. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.
Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH
Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224
[TBL] [Abstract][Full Text] [Related]
20. Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells.
Worrall JG; Whiteside TL; Prince RK; Buckingham RB; Stachura I; Rodnan GP
Arthritis Rheum; 1986 Jan; 29(1):54-64. PubMed ID: 3947417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
